LifeMD, Inc. (LFMDP)

US — Healthcare Sector

Peers: DNTH ELVN PLSE OPK ATAI NKTR CTEV SANA INBX PGEN

Automate Your Wheel Strategy on LFMDP

With Tiblio's Option Bot, you can configure your own wheel strategy including LFMDP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol LFMDP
Rev/Share 5.4664
Book/Share 0.073
PB 98.3428
Debt/Equity 4.9646
CurrentRatio 0.7251
ROIC 0.0686

MktCap 134780478.0
FreeCF/Share 0.3677
PFCF 7.9398
PE -28.084
Debt/Assets 0.0989
DivYield 0
ROE 2.2228

Rating D+
Score 1
Recommendation Strong Sell
P/E Score 1
DCF Score 1
P/B Score 1
D/E Score 1

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
No ratings available.

News

LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript

LFMD, LFMDP
Published: November 17, 2025 by: Seeking Alpha
Sentiment: Neutral

LifeMD, Inc. ( LFMD ) Q3 2025 Earnings Call November 17, 2025 4:30 PM EST Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG, LLC, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Anderson Schock - B. Riley Securities, Inc., Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Eduardo Martinez-Montes - H.C.

image for news LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript

LifeMD Reports Third Quarter 2025 Results

LFMD, LFMDP
Published: November 17, 2025 by: GlobeNewsWire
Sentiment: Neutral

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million. Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% to $2.9 million.

image for news LifeMD Reports Third Quarter 2025 Results

LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

LFMD, LFMDP
Published: November 04, 2025 by: GlobeNewsWire
Sentiment: Neutral

Transaction Values WorkSimpli at $65 Million Enterprise Value; Supports LifeMD's Strategic Focus on Scaling its Virtual Care and Pharmacy Businesses Transaction Values WorkSimpli at $65 Million Enterprise Value; Supports LifeMD's Strategic Focus on Scaling its Virtual Care and Pharmacy Businesses

image for news LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®

LFMD, LFMDP
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral

Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter

image for news LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®

LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript

LFMD, LFMDP
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral

LifeMD, Inc. (NASDAQ:LFMD ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor Fitzgerald Steve Dechert - KeyBanc Steven Valiquette - Mizuho Securities Yi Chen - H.C. Wainwright Anderson Schock - B.

image for news LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript

About LifeMD, Inc. (LFMDP)

IPO Date 2021-10-05
Website https://www.lifemd.com
Industry Medical - Pharmaceuticals
CEO Justin Schreiber
Employees 304

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.